Faculty Profiles - TANAKA Chie

Papers - TANAKA Chie

Division display 181 - 200 of about 216 ／ All the affair displays >>

FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer. Reviewed

Tanaka H, Kanda M, Shimizu D, Tanaka C, Kobayashi D, Hayashi M, Iwata N, Yamada S, Fujii T, Nakayama G, Sugimoto H, Fujiwara M, Niwa Y, Kodera Y

Annals of surgical oncology Vol. 24 ( 11 ) page： 3438 - 3445 2017.10

Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society. Reviewed

Yamada S, Fujii T, Takami H, Hayashi M, Iwata N, Kanda M, Tanaka C, Sugimoto H, Nakayama G, Koike M, Fujiwara M, Kodera Y

Surgery Vol. 162 ( 4 ) page： 784 - 791 2017.10

An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma. Reviewed

Kanda M, Murotani K, Sugimoto H, Miwa T, Umeda S, Suenaga M, Hayashi M, Hattori N, Tanaka C, Kobayashi D, Yamada S, Fujiwara M, Kodera Y

Oncotarget Vol. 8 ( 41 ) page： 71070 - 71079 2017.9

Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma. Reviewed

Umeda S, Kanda M, Sugimoto H, Tanaka H, Hayashi M, Yamada S, Fujii T, Takami H, Niwa Y, Iwata N, Tanaka C, Kobayashi D, Fujiwara M, Kodera Y

BMC cancer Vol. 17 ( 1 ) page： 610 2017.9

Involvement of the immunoregulator MZB1 in progression of gastric cancer

Tanaka Y., Kanda M., Tanaka C., Kobayashi D., Tanaka H., Takami H., Hayashi M., Iwata N., Niwa Y., Yamada S., Nakayama G., Sugimoto H., Koike M., Fujiwara M., Kodera Y.

ANNALS OF ONCOLOGY Vol. 28 page： . 2017.9

Nutritional recovery after open and laparoscopic distal gastrectomy for early gastric cancer: A prospective multicenter comparative trial (CCOG1204)

Tanaka, C; Kanda, M; Misawa, K; Ito, S; Ito, Y; Mochizuki, Y; Ishigure, K; Yaguchi, T; Teramoto, J; Nakayama, H; Kawase, Y; Fujiwara, M; Kodera, Y

ANNALS OF ONCOLOGY Vol. 28 2017.9

Usefulness of preoperative estimated glomerular filtration rate to predict complications after curative gastrectomy in patients with clinical T2-4 gastric cancer. Reviewed

Tanaka Y, Kanda M, Tanaka C, Kobayashi D, Mizuno A, Iwata N, Hayashi M, Niwa Y, Takami H, Yamada S, Fujii T, Nakayama G, Sugimoto H, Fujiwara M, Kodera Y

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association Vol. 20 ( 4 ) page： 736 - 743 2017.7

Stapling an extracorporeal Billroth-I anastomosis by the complete double stapling technique after laparoscopy-assisted distal gastrectomy. Reviewed

Tanaka C, Fujiwara M, Kanda M, Murotani K, Iwata N, Hayashi M, Kobayashi D, Yamada S, Nakayama G, Sugimoto H, Koike M, Fujii T, Kodera Y

Asian journal of endoscopic surgery Vol. 10 ( 2 ) page： 137 - 142 2017.5

Intraperitoneal Administration of Plasma-Activated Medium: Proposal of a Novel Treatment Option for Peritoneal Metastasis From Gastric Cancer. Reviewed

Takeda S, Yamada S, Hattori N, Nakamura K, Tanaka H, Kajiyama H, Kanda M, Kobayashi D, Tanaka C, Fujii T, Fujiwara M, Mizuno M, Hori M, Kodera Y

Annals of surgical oncology Vol. 24 ( 5 ) page： 1188 - 1194 2017.5

Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer. Reviewed

Inaoka K, Kanda M, Uda H, Tanaka Y, Tanaka C, Kobayashi D, Takami H, Iwata N, Hayashi M, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y

World journal of gastroenterology Vol. 23 ( 14 ) page： 2519 - 2526 2017.4

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902). Reviewed

Nakayama G, Ishigure K, Yokoyama H, Uehara K, Kojima H, Ishiyama A, Hayashi N, Takano N, Hattori N, Kobayashi D, Tanaka C, Hayashi M, Kanda M, Yamada S, Sugimoto H, Koike M, Fujiwara M, Fujii T, Murotani K, Ando Y, Kodera Y

BMC cancer Vol. 17 ( 1 ) page： 243 2017.4

Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study. Reviewed

Ninomiya G, Fujii T, Yamada S, Yabusaki N, Suzuki K, Iwata N, Kanda M, Hayashi M, Tanaka C, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y

International journal of surgery (London, England) Vol. 39 page： 45 - 51 2017.3

GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer. Reviewed

Shimizu D, Kanda M, Tanaka H, Kobayashi D, Tanaka C, Hayashi M, Iwata N, Niwa Y, Takami H, Yamada S, Fujii T, Nakayama G, Fujiwara M, Kodera Y

Scientific reports Vol. 7 page： 42089 2017.2

Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma.

Ninomiya, G; Fujii, T; Yamada, S; Asano, T; Takano, N; Takami, H; Iwata, N; Kanda, M; Niwa, Y; Hayashi, M; Kobayashi, D; Tanaka, C; Nakayama, G; Sugimoto, H; Fujiwara, M; Koike, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 35 ( 4 ) 2017.2

Clinical implication of inflammation-based prognostic score and perioperative nutrition control in pancreatic cancer.

Takano, N; Yamada, S; Fujii, T; Tashiro, M; Tanaka, N; Morimoto, D; Ninomiya, G; Niwa, Y; Takami, H; Iwata, N; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 35 ( 4 ) 2017.2

Conversion surgery for unresectable gastric cancer following complete response of distant metastasis by systemic chemotherapy.

Kobayashi, D; Kanda, M; Tanaka, C; Iwata, N; Hayashi, M; Yamada, S; Nakayama, G; Sugimoto, H; Koike, M; Fujii, T; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 35 ( 4 ) 2017.2

Tumor infiltrative pattern predicts sites of recurrence after curative gastrectomy for gastric cancer.

Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Fujii, T; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 35 ( 4 ) 2017.2

The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy. Reviewed

Shimizu D, Kanda M, Sugimoto H, Shibata M, Tanaka H, Takami H, Iwata N, Hayashi M, Tanaka C, Kobayashi D, Yamada S, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y

International journal of oncology Vol. 50 ( 2 ) page： 381 - 386 2017.2

Proposal of the Coagulation Score as a Predictor for Short-Term and Long-Term Outcomes of Patients with Resectable Gastric Cancer. Reviewed

Kanda M, Tanaka C, Kobayashi D, Mizuno A, Tanaka Y, Takami H, Iwata N, Hayashi M, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y

Annals of surgical oncology Vol. 24 ( 2 ) page： 502 - 509 2017.2

The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer

Kataoka, M; Kanda, M; Ishigure, K; Matsuoka, H; Sato, Y; Takahashi, T; Tanaka, C; Deguchi, T; Shibata, Y; Sato, M; Inagaki, H; Matsui, T; Kondo, A; Takano, N; Tanaka, H; Sakamoto, J; Oba, K; Kondo, K

ANNALS OF SURGICAL ONCOLOGY Vol. 24 ( 2 ) page： 546 - 553 2017.2

　 PREV - NEXT 　

<TANAKA Chie>

Papers - TANAKA Chie